Fr., 13. Mai|
Eye drops for the treatment of myopia – Developing a successful launch strategy for "All-clear eye drops"
Zeit & Ort
13. Mai 2022, 18:00 – 20:00
München, Geschwister-Scholl-Platz, 80539 München, Deutschland
Über das Event
Getting the launch strategy of a new product right is of utmost importance for companies in the healthcare industry. Accordingly, it requires a thorough understanding of the competitive landscape and careful evaluation of the market potential from multiple perspectives to define the right price tag and product positioning strategy.
Furthermore, in defining the right strategy, perspectives from multiple stakeholders have to be considered, ranging from patients and physicians to sick funds and regulatory authorities.
In the upcoming event, we will work with you to develop a launch strategy for an innovative medicine treating a widespread eye disorder (myopia, i.e. short-sightedness)! Note that no previous experience in the Healthcare/Life Science industry is required. Each group will be accompanied by two of our experienced consultants and will later present their results and specific recommendations.
Simon-Kucher & Partners is a global consultancy with about 1,700 employees in offices worldwide. We focus on TopLine Power® and growth; our expertise in marketing and sales are ranked among the deepest and broadest in the consulting world. Our teams help clients grow revenue and profits rather than cutting costs. We are also renowned as the world’s best pricing consultancy.
Unlike cost-cutting initiatives, our work in growing clients’ revenue and profit has no natural limits. As long as consumers, technologies, and business environments keep changing, companies will need help with monetizing their products.
Simon-Kucher’s common values include integrity, respect, team spirit, and entrepreneurship. Employees on all levels especially live up to the latter: Our partners are not only owners of the company, they are also entrepreneurs in the truest sense of the word. Every day, they are driving forward our firm’s economic success and future development.